The Fibroscan CAP, or FibroScan 502 Touch-CAP, is a state-of-the-art medical device that uses the most advanced non-invasive technology.
It is a non-invasive, painless and reproducible method that provides useful information to assess the treatment, follow-up or short- or long-term prognosis of all stages of chronic liver disease.
The liver volume explored with the FibroScan probe is at least 100 times greater than with a liver biopsy.
Every patient is different and our FibroScan 502 Touch has 2 ergonomic adult probes, M-standard and XL-overweight connected simultaneously, which guarantee an effective diagnosis for all clinical and morphological needs of patients who previously could not benefit from this examination.
More information about Fibroscan
